PT Charlie Hospital Semarang Tbk (IDX:RSCH)
392.00
+2.00 (0.51%)
At close: Dec 5, 2025
IDX:RSCH Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 58,836 | 48,502 | 42,160 | 33,033 | 35,558 | 13,264 |
| Revenue Growth (YoY) | 23.25% | 15.04% | 27.63% | -7.10% | 168.08% | - |
| Cost of Revenue | 49,665 | 35,239 | 30,213 | 29,841 | 20,256 | 9,173 |
| Gross Profit | 9,171 | 13,263 | 11,947 | 3,193 | 15,302 | 4,091 |
| Selling, General & Admin | 15,753 | 12,367 | 13,364 | 8,049 | 7,982 | 4,374 |
| Other Operating Expenses | 633.74 | 969.26 | - | 1,249 | 1,432 | 1,172 |
| Operating Expenses | 23,719 | 16,321 | 13,364 | 11,988 | 11,781 | 7,995 |
| Operating Income | -14,549 | -3,058 | -1,417 | -8,796 | 3,520 | -3,904 |
| Interest Expense | -8,749 | -1,410 | - | - | - | - |
| Interest & Investment Income | 34.91 | 41.84 | 43.25 | 33.57 | 8.91 | 2.5 |
| Other Non Operating Income (Expenses) | -326.9 | 361.2 | 61.26 | -152.77 | 21.43 | 18.3 |
| EBT Excluding Unusual Items | -23,590 | -4,065 | -1,312 | -8,915 | 3,550 | -3,883 |
| Asset Writedown | -24.38 | -24.38 | - | - | - | - |
| Pretax Income | -23,614 | -4,090 | -1,312 | -8,915 | 3,550 | -3,883 |
| Income Tax Expense | -5,429 | -577.08 | -200.68 | -1,560 | 810.09 | - |
| Net Income | -18,167 | -3,512 | -1,112 | -7,355 | 2,740 | -3,883 |
| Net Income to Common | -18,167 | -3,512 | -1,112 | -7,355 | 2,740 | -3,883 |
| Shares Outstanding (Basic) | 2,650 | 2,650 | 2,303 | 1,000 | 1,000 | 49 |
| Shares Outstanding (Diluted) | 2,650 | 2,650 | 2,303 | 1,000 | 1,000 | 49 |
| Shares Change (YoY) | - | 15.05% | 130.33% | - | 1923.39% | - |
| EPS (Basic) | -6.86 | -1.33 | -0.48 | -7.35 | 2.74 | -78.57 |
| EPS (Diluted) | -6.86 | -1.33 | -0.48 | -7.35 | 2.74 | -78.57 |
| Free Cash Flow | -101,677 | -40,212 | -62,216 | -16,095 | -12,011 | -8,979 |
| Free Cash Flow Per Share | -38.37 | -15.17 | -27.01 | -16.09 | -12.01 | -181.68 |
| Gross Margin | 15.59% | 27.35% | 28.34% | 9.66% | 43.03% | 30.84% |
| Operating Margin | -24.73% | -6.31% | -3.36% | -26.63% | 9.90% | -29.43% |
| Profit Margin | -30.88% | -7.24% | -2.64% | -22.26% | 7.71% | -29.28% |
| Free Cash Flow Margin | -172.81% | -82.91% | -147.57% | -48.72% | -33.78% | -67.69% |
| EBITDA | 3,813 | 5,409 | 4,322 | -3,287 | 7,916 | 82.86 |
| EBITDA Margin | 6.48% | 11.15% | 10.25% | -9.95% | 22.26% | 0.63% |
| D&A For EBITDA | 18,361 | 8,467 | 5,739 | 5,509 | 4,396 | 3,987 |
| EBIT | -14,549 | -3,058 | -1,417 | -8,796 | 3,520 | -3,904 |
| EBIT Margin | -24.73% | -6.31% | -3.36% | -26.63% | 9.90% | -29.43% |
| Effective Tax Rate | - | - | - | - | 22.82% | - |
Source: S&P Capital IQ. Standard template. Financial Sources.